-
Natco Pharma jumps on seeking approval for Molnupiravir
Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir
-
COVID infection rises 3,800% in Bengal since the announcement of assembly elections
Doctors feel daily infection figure may touch 15,000 if all protocols are not maintained properly
-
Private hospitals told to reserve 50% of beds for COVID patients
The private hospitals have agreed to reserve 50% beds for COVID-19 patients within a week. Patients without symptoms and with mild symptoms will be is
